AAPS PharmSci 360 2026: Formulation Partnerships With Mikart

AAPS PharmSci 360 is a flagship event for pharmaceutical scientists focused on advancing drug development through formulation science and technical innovation. In 2026, the meeting will convene researchers, formulators, and development leaders to share insights on translating promising molecules into robust oral solid and liquid dosage forms.

Core themes include addressing formulation challenges such as solubility, stability, and manufacturability, while designing dosage forms tailored to specific patient populations, including pediatric and geriatric groups. The program emphasizes connecting early‑stage formulation work with the realities of scale‑up, tech transfer, and commercial manufacturing to avoid delays and rework later in development.

Discussions also explore how analytical development and stability understanding support regulatory readiness and CMC decision‑making. For scientists and development teams seeking to bridge bench‑level innovation with clinical and commercial execution, the meeting offers practical perspectives on building scalable, patient‑centric formulations that remain viable throughout the product lifecycle.